Compare WEA & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WEA | EDAP |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.2M | 128.9M |
| IPO Year | N/A | 1998 |
| Metric | WEA | EDAP |
|---|---|---|
| Price | $10.58 | $3.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 30.9K | 23.9K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 7.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $10.30 | $1.21 |
| 52 Week High | $11.44 | $5.05 |
| Indicator | WEA | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 42.19 |
| Support Level | $10.30 | $3.13 |
| Resistance Level | $11.33 | $3.44 |
| Average True Range (ATR) | 0.13 | 0.21 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 7.00 | 37.93 |
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.